Download Files:
PHCCC
SKU
HY-100409-10 mg
Category Reference compound
Tags Cancer, GPCR/G Protein;Neuronal Signaling, mGluR
$50 – $780
Products Details
Product Description
– PHCCC is a Group I mGluR antagonist with an IC50 of 3 μM. PHCCC is a selective positive modulator of mGlu4 receptor. Antiparkinsonian effect[1][2].
Web ID
– HY-100409
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C17H14N2O3
References
– [1]Marino MJ et al. Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson’s disease treatment. Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13668-73.|[2]Récasens M, et al. Metabotropic glutamate receptors as drug targets. Curr Drug Targets. 2007;8(5):651-681.
CAS Number
– 179068-02-1
Molecular Weight
– 294.30
Compound Purity
– 99.96
SMILES
– O=C(C12C(C2)/C(C3=CC=CC=C3O1)=NO)NC4=CC=CC=C4
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 12.5 mg/mL (ultrasonic)
Target
– mGluR
Isoform
– mGluR
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.